Note 2 - Purchase Price Allocation (Details) - USD ($)	Feb. 18, 2014
Totipotent RX Corporation [Member]
Purchase Price:
ThermoGenesis common shares and warrants	$ 27,287,000
Fair value of assets acquired:
Cash	351,000
Receivables	171,000
Inventories	191,000
Clinical protocols	19,870,000
Other intangible assets	2,187,000
Property and equipment	384,000
Other assets	132,000
Total assets	23,286,000
Fair value of liabilities assumed:
Accounts payable	514,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt	337,000
Deferred tax liability	8,048,000
Other liabilities	295,000
Total liabilities	9,194,000
Net assets acquired	14,092,000
Goodwill	$ 13,195,000